EDIGENE

Biological preparations for medical purposes for the treatment of gene mutation related diseases, hematological diseases and psychiatric and immune system related diseases and disorders; styptic preparations; medicines for human purposes, namely, medicines for the treatment of diabetes, obesity, cancer, viral, metabolic, endocrine, musculoskeletal, oncological diseases, cardiovascular and cerebrovascular diseases, respiratory diseases and asthma, gastrointestinal diseases, genitourinary diseases, neurological diseases, allergies, headaches, insomnia, bacteria-based diseases, ocular disorders or diseases; pharmaceutical preparations, namely, antivirals, pharmaceutical preparations for suppressing tumors, pharmaceutical preparations for the treatment of cancers; stem cells for medical purposes; surgical implants comprised of living tissues; blood for medical purposes; biological preparations for the treatment of cancer; pharmaceutical preparations for activating cellular function; cytostatics for medical purposes; living cells for medical use; ophthalmological preparations; pharmaceutical products for ophthalmological use; cord blood for medical purposes

Biotechnology research; scientific research for medical purposes in the area of cancerous diseases; genetic testing for scientific research purposes; structural and functional analysis of genomes; DNA screening for scientific research purposes; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical research services; analysis of the mode of action of chemical combinations on animals; technological research in the field of novel drug development; scientific laboratory services; chemical research; biological research; scientific research in the nature of conducting clinical trials for others; medical research